Triamcinolone
Quick Overview
| Attribute | Value |
|---|---|
| Drug Name | Triamcinolone |
| DrugBank ID | DB00620 |
| KG Predictions | 645 |
| DL Predictions (≥0.7) | 637 |
| Evidence Level | L5 |
| NPRA Status | Approved |
Sample Brand Names in Malaysia
Predicted Indications
This drug has 645 knowledge graph predictions and 637 high-confidence deep learning predictions.
Top KG Predictions
| Indication | Source |
|---|---|
| erythema multiforme | KG |
| lymphosarcoma | KG |
| disease of orbital region | KG |
| leukemia, lymphocytic, susceptibility to | KG |
| rheumatic heart disease | KG |
| exfoliative dermatitis | KG |
| chronic beryllium disease | KG |
| seborrheic dermatitis | KG |
| exostosis | KG |
| primary cutaneous T-cell non-Hodgkin lymphoma | KG |
FHIR Resources
Access drug data via FHIR R4 API:
- MedicationKnowledge:
/fhir/MedicationKnowledge/DB00620
Related Resources
| Resource | Link |
|---|---|
| DrugBank | View on DrugBank |
| PubMed | Search PubMed |
| ClinicalTrials.gov | Search Trials |
Disclaimer
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.